Results 61 to 70 of about 21,677 (267)

Light‐Based Molecular Tools to Precisely Monitor and Operate β‐Adrenoceptors

Medicinal Research Reviews, Volume 46, Issue 2, Page 445-474, March 2026.
ABSTRACT β‐Adrenoceptors are important G protein–coupled receptors involved in cardiovascular, metabolic, and neurological regulation. To study their function with high precision, light‐based molecular tools have been developed offering precise spatiotemporal control.
Ignazzitto Maria Tindara, Gómez‐Santacana Xavier, Llebaria Amadeu, Rovira Xavier   +3 more
wiley   +1 more source

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease

International Journal of COPD, 2020
Donald P Tashkin Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USACorrespondence: Donald P TashkinDavid Geffen School of Medicine at UCLA, 10388 Le Conte Avenue, Los Angeles, CA 90095, USATel +1 310 825 3163Fax +1 310 ...
Tashkin DP
doaj  

Projections of Healthcare Resource Utilization and Costs Related to Exacerbations for Budesonide/Glycopyrrolate/Formoterol Fumarate Versus Dual Long-Acting Muscarinic Antagonist/Long-Acting β ₂ -Agonist and Inhaled Corticosteroid/Long-Acting β ₂ -Agonist Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease [PDF]

, 2021
Enrico De Nigris, Catrin Treharne, N. Brighton, Ulf Holmgren, Ann C. Walker, John Haughney   +5 more
openalex   +1 more source

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD [PDF]

, 2014
Dirkje S Postma,1 Nicolas Roche,2 Gene Colice,3 Elliot Israel,4 Richard J Martin,5 Willem MC van Aalderen,6 Jonathan Grigg,7 Anne Burden,8 Elizabeth V Hillyer,8 Julie von Ziegenweidt,8 Gokul Gopalan,9 David Price8,10 1University of Groningen, Department ...
Burden, A, Colice, G, Gopalan, G, Grigg, J, Hillyer, EV, Israel, E, Martin, RJ, Postma, DS, Price, D, Roche, N, van Aalderen, WMC, von Ziegenweidt, J   +11 more
core   +6 more sources

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Formoterol in the management of chronic obstructive pulmonary disease

International Journal of COPD, 2008
Paschalis Steiropoulos, Argyris Tzouvelekis, Demosthenes BourosDepartment of Pneumonology, University Hospital of Alexandroupolis, GreeceAbstract: Bronchodilators represent the hallmark of symptomatic treatment of Chronic Obstructive Pulmonary Disease ...
Paschalis Steiropoulos, Argyris Tzouvelekis, Demosthenes Bouros   +2 more
doaj  

Electrochemical Studies of Expired Drug (Formoterol) as Oilfield Corrosion Inhibitor for Mild Steel in H2SO4 Media

International Journal of Electrochemical Science, 2020
The expired drug Formoterol (EDF) [N-(2-hydroxy-5-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide] was examined as potential corrosion inhibitor of mild steel in 1 M sulphuric acid (H2SO4) media using weight loss ...
Xiangrong Ma, Rui Dang, Yuhong kang, Ying Gong, Jiao Luo, Yuanyuan Zhang, Jiawei Fu, Chunyan Li, Yajun Ma   +8 more
doaj   +1 more source

Comparative efficacy of leukotriene modifier and inhaled corticosteroids in the complex treatment of steroid-naive patients with bronchial asthma combined with chronic obstructive pulmonary disease with neutrophilic type of inflammation

Zaporožskij Medicinskij Žurnal, 2021
The aim: to compare the efficacy and tolerability of the leukotriene modifier and inhaled corticosteroids in combination with long-acting β2-agonist formoterol in steroid-naive patients with asthma combined with COPD with neutrophilic inflammation ...
Yu. I. Feshchenko, L. O. Yashyna, V. I. Ihnatieva, M. O. Polianska, S. H. Opimakh, I. V. Zvol, S. M. Moskalenko, H. L. Humeniuk, N. A. Vlasova, L. A. Halai   +9 more
doaj   +1 more source

Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD [PDF]

, 2010
In the present study, we examined whether there is a difference in the onset of bronchodilatation between formoterol/beclomethasone 12/200 μg Modulite and formoterol/budesonide 9/320 μg Turbuhaler in patients with COPD.
Biscione, G, Cardaci, V, Cazzola, M, Ferri, L, Matera, MG, Pasqua, F   +5 more
core   +1 more source

Successful Catheter‐Directed Thrombolysis for a Patient With Intermediate‐High‐Risk Pulmonary Embolism: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Acute pulmonary embolism (PE) is a prevalent cardiovascular condition with significant mortality and morbidity. Treatment strategies vary according to risk stratification. While anticoagulation is sufficient for low‐risk patients, high‐risk cases often necessitate systemic thrombolysis (ST) or surgical embolectomy.
Mohammadreza Motazedian, Ahoura Salehi Nowbandegani, Zahra Mohammadi, Sina Bazmi   +3 more
wiley   +1 more source